SVB Leerink analyst Danielle Antalffy maintains Abbott Laboratories (NYSE:ABT) with a Market Perform and raises the price target from $115 to $128.
Donaldson Clocks 18% Sales Growth In Q2; Raises FY22 Sales, EPS Guidance
Donaldson Co Inc (NYSE:DCI) reported second-quarter FY22 sales growth of 18.2% year-over-year to $802.5 million, beating the consensus of $768.71 million.…